Pharmabiz58m
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer: Tokyo Saturday, October 5, 2024, 10:00 Hrs [IST] Daiich ...
Pharmabiz1h
WHO approves Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay for emergency use
WHO approves Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay for emergency use: Geneva Saturday, October 5, 2024, 09:00 Hrs [IST] The World Health Organization (WH ...
Pharmabiz2h
India’s pool of pharmacognosists needs to take up leadership roles: Dr DBA Narayana
India’s pool of pharmacognosists needs to take up leadership roles: Dr DBA Narayana: Nandita Vijayasimha, Bengaluru Saturday, October 5, 2024, 08:00 Hrs [IST] India’s pool of ...
Pharmabiz2h
MGR Medical University & TN IDMA join hands for industry-institution tie-up for pharmacy education
MGR Medical University & TN IDMA join hands for industry-institution tie-up for pharmacy education: Peethaambaran Kunnathoor, Chennai Saturday, October 5, 2024, 08:00 Hrs [IST] Se ...
Pharmabiz2h
NABL issues clarification to laboratories regarding fraudulent payment requests
NABL issues clarification to laboratories regarding fraudulent payment requests: Shardul Nautiyal, Mumbai Saturday, October 5, 2024, 08:00 Hrs [IST] The National Accreditation Boa ...
Pharmabiz2h
NIMHANS to implement community based programmes to reduce stigma around mental health issues
NIMHANS to implement community based programmes to reduce stigma around mental health issues: Nandita Vijayasimha, Bengaluru Saturday, October 5, 2024, 08:00 Hrs [IST] The Karnata ...
Pharmabiz2h
NITI Aayog report calls for PPP model for drug development to address pandemic situations
NITI Aayog report calls for PPP model for drug development to address pandemic situations: Our Bureau, New Delhi Saturday, October 5, 2024, 08:00 Hrs [IST] A public-private partne ...
Pharmabiz16h
Ingenza announces move to purpose-built facilities to expand fermentation and research capacity
Ingenza announces move to purpose-built facilities to expand fermentation and research capacity: United Kingdom Friday, October 4, 2024, 18:00 Hrs [IST] Ingenza, a world-leading c ...
Pharmabiz17h
Max Institute of Cancer Care concludes Max Onco Updates 2024, fostering collaboration and accelerating progress in the fight against cancer
Max Institute of Cancer Care concludes Max Onco Updates 2024, fostering collaboration and accelerating progress in the fight against cancer: Our Bureau, Mumbai Friday, October 4, ...
Pharmabiz17h
BioDuro-Sundia launches new compound management centre, strengthening drug discovery services
BioDuro-Sundia launches new compound management centre, strengthening drug discovery services: Irvine, California Friday, October 4, 2024, 17:00 Hrs [IST] BioDuro-Sundia, a leadin ...
Pharmabiz18h
Liquidia, Pharmosa Biopharm expand collaboration to develop sustained release inhaled treprostinil
Liquidia, Pharmosa Biopharm expand collaboration to develop sustained release inhaled treprostinil: Morrisville, North Carolina Friday, October 4, 2024, 16:00 Hrs [IST] Liquidia C ...
Pharmabiz19h
University of Central Lancashire signs MoU with Brinton Healthcare for nanotechnology research
University of Central Lancashire signs MoU with Brinton Healthcare for nanotechnology research: Our Bureau, Mumbai Friday, October 4, 2024, 15:45 Hrs [IST] The University of Centr ...